Investing In A Life Sci Or Tech Startup? Follow The Data, Not The Herd

Published: Aug 05, 2016

The much ballyhooed rise and sudden demise of Theranos is a cautionary tale for anyone interested in investing in early-stage biotechnology companies.

The main lesson is not “Stay on the sidelines.” Instead, it’s invest with your eyes wide open. If we are going tackle major challenges in fighting disease, early-stage investors must continue to invest in breakthrough science and technology startups.

Back to news